A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Institut Curie
Children's Hospital of Philadelphia
Institut Curie
Seattle Children's Hospital
Seattle Children's Hospital
St. Jude Children's Research Hospital
Phoenix Children's Hospital
St. Jude Children's Research Hospital
Medical College of Wisconsin
Eye & ENT Hospital of Fudan University
Washington University School of Medicine
Targeted Therapy Technologies, LLC